This announcement is a separate document:
自愿披露关于GR1802注射液儿童和青少年特应性皮炎适应症获得药物临床试验批准通知书的公告
Voluntary disclosure of the announcement on the approval of the drug clinical trial approval notice for the indication of GR1802 injection for children and adolescents with atopic dermatitis.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.